Testing a financial impact assessment tool in patients diagnosed with metastatic colorectal cancer

Study ID: S1417CD

Financial impact assessment tool in patients with metastatic colorectal cancer

This study tests the use of a financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial impact of cancer and help patients avoid financial problems during treatment.

Participants will complete questionnaires asking for personally identifiable information, such as name, address, birth date and social security numbers for the purposes of the researchers to access their credit report data. Participants will be asked to complete the questionnaires at the time of registration in the study and then at intervals during the study, namely at three, six, nine and 12 months. Caregivers of participants may also complete questionnaires.

Inclusion criteria:

  • Newly diagnosed metastatic colon or rectal cancer (mCRC) after prior treatment for stage I-III disease and be within 120 days after diagnosis at time of registration
  • Systemic chemotherapy and/or systemic biologic therapy must be planned to be administered within 30 days after registration or must have been initiated within 60 days prior to registration
  • Patients who are planning palliative or hospice care only (no chemotherapy or biologic therapy) are not eligible
  • Patients must plan to receive treatment at the registering site; registering site must be an NCORP site (Main Line Health is an NCORP site)
  • Patients must provide their full name, primary address in the U.S., birth date and social security number at registration for the purposes of accessing credit report data

Patients will complete questionnaires (baseline, financial/employment impact, insurance impact, quality of life, and treatment perceptions), which should take 30 to 60 minutes at baseline and at three, six, nine and 12 months. Caregivers (optional) complete questionnaires over 30–60 minutes at baseline and at six and 12 months.

Inclusion Snapshot

  • Must have been diagnosed with metastatic colorectal cancer no more than four months ago
  • Must be willing to share sensitive personally identifiable information

Contact Information

Lankenau Institute for Medical Research trial